New leaders named to Vanderbilt-Ingram research programs

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs. Martha Shrubsole, PhD (Epidemiology), joins Xiao-Ou Shu, MD, PhD, MPH, Ingram Professor of Cancer Research (Epidemiology), as a co-leader of the Cancer Epidemiology Research Program. Vandana Abramson, MD (Hematology and Oncology), joins Justin Balko, PharmD, PHD (Hematology and Oncology), as a co-leader of the Breast Cancer Research Program. Kristen Ciombor, MD, MSCI (Hematology and Oncology), join Douglas Johnson, MD, MSCI (Hematology and Oncology), to lead theTranslational Research and Interventional Oncology Research Program.